Diagnosis and classification of myelodysplastic syndromes.
Hasserjian RP, Germing U, Malcovati L.
Blood. 2023 Dec 28;142(26):2247-2257. doi: 10.1182/blood.2023020078.
New Approaches to Myelodysplastic Syndrome Treatment.
Bazinet A, Bravo GM.
Curr Treat Options Oncol. 2022 May;23(5):668-687. doi: 10.1007/s11864-022-00965-1. Epub 2022 Mar 23.
Hypocellular Philadelphia chromosome-positive mixed-phenotype acute leukemia successfully treated with dasatinib: A case report.
Lee S, Fujita K, Wakayama H, Kito Y, Hara T, Tsurumi H.
Mol Clin Oncol. 2022 Feb;16(2):33. doi: 10.3892/mco.2021.2466. Epub 2021 Dec 14.
Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients.
Al-Kali A, Konoplev S, Lin E, Kadia T, Faderl S, Ravandi F, Ayoubi M, Brandt M, Cortes JE, Kantarjian H, Borthakur G.
Haematologica. 2012 Feb;97(2):235-40. doi: 10.3324/haematol.2011.046672. Epub 2011 Nov 4.
How I treat myelodysplastic syndromes of childhood.
Locatelli F, Strahm B.
Blood. 2018 Mar 29;131(13):1406-1414. doi: 10.1182/blood-2017-09-765214. Epub 2018 Feb 8.
MDS overlap disorders and diagnostic boundaries.
Tanaka TN, Bejar R.
Blood. 2019 Mar 7;133(10):1086-1095. doi: 10.1182/blood-2018-10-844670. Epub 2019 Jan 22.
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.
Gress V, Roussy M, Boulianne L, Bilodeau M, Cardin S, El-Hachem N, Lisi V, Khakipoor B, Rouette A, Farah A, Théret L, Aubert L, Fatima F, Audemard É, Thibault P, Bonneil É, Chagraoui J, Laramée L, Gendron P, Jouan L, Jammali S, Paré B, Simpson SM, Tran TH, Duval M, Teira P, Bittencourt H, Santiago R, Barabé F, Sauvageau G, Smith MA, Hébert J, Roux PP, Gruber TA, Lavallée VP, Wilhelm BT, Cellot S.
Blood Adv. 2024 Jan 9;8(1):112-129. doi: 10.1182/bloodadvances.2022008899.
Clinical features and outcomes of hypocellular acute myeloid leukemia in adults: A Korean AML registry data.
Song IC, Jo DY, Kim HJ, Min YH, Hong DS, Lee WS, Shin HJ, Lee JH, Park J, Kim HJ.
Medicine (Baltimore). 2021 Jan 8;100(1):e24185. doi: 10.1097/MD.0000000000024185.
Clinical Characteristics and Treatment Outcome of Hypocellular Acute Myeloid Leukemia Based on WHO Classification.
Čolović N, Denčić-Fekete M, Peruničić M, Jurišić V.
Indian J Hematol Blood Transfus. 2020 Jan;36(1):59-63. doi: 10.1007/s12288-019-01161-2. Epub 2019 Jul 19.
The spectrum of GATA2 deficiency syndrome.
Calvo KR, Hickstein DD.
Blood. 2023 Mar 30;141(13):1524-1532. doi: 10.1182/blood.2022017764.
